Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.41 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | SDCBP | O00560 | 2/20 | 0.38 |
| ▸ | SDC2 | P34741 | 2/20 | 0.38 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4743495 | 1.00 | FAAH (0.42) | FAAHHDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8644196 | 0.89 | FAAH (0.52) | FAAHMEN1MAPK1KMT2APLA2G2A | |
| SCHEMBL8644193 | 0.89 | FAAH (0.52) | FAAHMEN1MAPK1KMT2APLA2G2A | |
| SCHEMBL9831703 | 0.87 | FAAH (0.59) | FAAHMEN1MAPK1KMT2APLA2G2A | |
| SCHEMBL11047677 | 0.87 | FAAH (0.59) | FAAHMEN1MAPK1KMT2APLA2G2A | |
| SCHEMBL6138003 | 0.87 | FAAH (0.59) | FAAHMEN1MAPK1KMT2APLA2G2A | |
| SCHEMBL6256412 | 0.86 | PLA2G2A (0.54) | FAAHHDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL1734627 | 0.86 | PLA2G2A (0.54) | FAAHHDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL28220811 | 0.86 | HDAC3 (0.43) | FAAHHDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL28220813 | 0.86 | HDAC3 (0.43) | FAAHHDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4859653-A | Use of compositions of matter containing N-acylates of alpha aminoacids for the treatment of skin | MORELLE JEAN V (FR) | 1989-08-22 | — | — | US | claimed |
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2025-01-02 | — | — | US | disclosed |
| EP-4433093-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-09-25 | — | — | EP | disclosed |
| CN-118488855-A | Solid composition comprising peptide or protein and acylated amino acid | 阿道恰公司 | 2024-08-13 | — | — | CN | disclosed |
| EP-4299057-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023084118-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2023-05-19 | — | — | WO | disclosed |
| EP-4180060-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2023-05-17 | — | — | EP | disclosed |
| CN-104086633-B | Short fatty acid tail polymyxin derivatives and application thereof | 北方抗生素有限公司 | 2018-02-09 | — | — | CN | disclosed |
| CN-103379911-B | PGC-1 alpha modulating peptides | LIPOTEC, S.A. (ES) | 2016-05-25 | — | — | CN | disclosed |
| CN-105050584-A | Topical formulations of corticosteroids with enhanced bioavailability | PREC DERMATOLOGY INC | 2015-11-11 | — | — | CN | disclosed |
| CN-104363893-A | Cyclodextrin-based microemulsions and their use for skin disorders | PREC DERMATOLOGY INC | 2015-02-18 | — | — | CN | disclosed |
| US-20140234903-A1 | BIOSYNTHETIC GENE CLUSTER FOR THE PRODUCTION OF PEPTIDE/PROTEIN ANALOGUES | ETH ZURICH (CH) | 2014-08-21 | — | — | US | disclosed |
| CN-103169626-A | Stabilizing method for external composition | ROHTO PHARMA | 2013-06-26 | — | — | CN | disclosed |
| CN-102793632-A | Component for external use | ROHTO PHARMA | 2012-11-28 | — | — | CN | disclosed |
| EP-2242765-A1 | SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF | Northern Antibiotics Oy (FI) | 2010-10-27 | — | — | EP | disclosed |
| WO-2009098357-A1 | SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF | NORTHERN ANTIBIOTICS OY (FI) | 2009-08-13 | — | — | WO | disclosed |
| EP-2057185-A1 | POLYMYXIN DERIVATIVES AND USES THEREOF | Northern Antibiotics Oy (FI) | 2009-05-13 | — | — | EP | disclosed |
| WO-2008017734-A1 | POLYMYXIN DERIVATIVES AND USES THEREOF | NORTHERN ANTIBIOTICS OY (FI) | 2008-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | NPPA, BCAT1, ANPEP | FAAH 858/4885HDAC3 752/4885HDAC1 782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.